U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. News & Events for Human Drugs
  4. From Our Perspective
  1. News & Events for Human Drugs

From Our Perspective

Education Efforts to Help Increase Biosimilar Understanding and Acceptance

By: Sarah Ikenberry, M.A., Senior Communication Advisor, Office of Therapeutic Biologics and Biosimilars, Office of New Drugs, CDER

A biosimilar is a biological product that is highly similar to and has no clinically meaningful differences from an existing FDA-approved biological product (biologic), also known as a reference product. Biosimilars are proven to be a safe and effective alternative to the reference product and may be offered at a lower cost.

More with Sarah Ikenberry


Previous From Our Perspectives






Back to Top